26 May 2023
Research presented at the European Congress on Obesity has identified a link between semaglutide, a common weight-loss drug, and a notable reduction in cardiovascular risks in patients with obesity after one year of use. The study concludes the importance of weight-loss in these improvements.
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024
Risk of depression during menopause transition not universal
11 Apr 2024
Patients with long Covid continue to show inflammatory proteins in blood
11 Apr 2024
People with obesity and high weight linked to feeling increased pain intensity
11 Apr 2024